1. Intermittent catheterization was done on 36 patients, 34 with traumatic and 2 with medical cord lesions; 28 (77.7%) patients became catheter free. 2. Intermittent catheterization was performed at first at 4 hours interval, which was extended to 6, 8, 12, 24, 48 and 72 hours depending on the progress recorded in a special chart. 3. Medication consisted of Methenamine mandelate, Ascorbic Acid and when not contraindicated, Betanechol. 4. Of the 28 catheter-free patients, 16 (57%) had a sterile urine. 5. Of 12 patients with sterile urine, 6 (50%) retained a sterile urine; the urine became sterile in 10 of 24 patients who had urinary infection on admission. 6. The majority, namely 21 of the 28 patients became catheter free within 60 days of intermittent catheterization; 10 of the 21 patients became catheter free within 30 days. Intermittent catheterization may be done for up to 3 months. 7. The shorter the period of preceding indwelling catheterization, the quicker is recovery of bladder function; however, long lasting preceding indwelling catheterization does not necessarily militate against a trial with intermittent catheterization; in spite of urinary infection, it may result in recovery of bladder function and sterile urine. 8. Bladder function seemed to respond more readily in patients with incomplete than with complete lesions, and in patients with lower motor neuron than upper motor neuron lesions. 9. The age of the patient did not seem to play a role for recovery of bladder function. 10. The urinary flora ranged from A. aerogenes, Pseudomonas aeroginosa, Proteus, E. Coli, Paracolon to non-hemolytic staph. aureus and diphtheroids, in the order of frequency on admission; changes of the flora occurred without and with medication. 11. The results are discussed in the light of the literature. 12. A plea is made to use this method for patients with cord lesion from the very start and to avoid indwelling catheterization.

This content is only available via PDF.
© 1967 S. Karger AG, Basel
1967
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.